Sleeve Gastrectomy With Cruroplasty and Omental Rape for Treatment of Morbid Obesity With Reflux Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-12

Study Completion Date

2023-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

in this study the investigators will test anew technique to mange patients with morbid obesity and GERD by doing sleeve gastrectomy plus cruroplasty and omental rape around the gastroesophageal junction

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass

NCT00951093

Gastroesophageal Reflux Disease Morbid Obesity

COMPLETED

Treatment of Reflux With Sleeve Gastrectomy

NCT06170060

Reflux Disease, Gastro-Esophageal Hiatal Hernia Reflux Esophagitis

ACTIVE_NOT_RECRUITING NA

Prevalence, Predictors and Management of Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy

NCT05416645

Gastroesophageal Reflux

COMPLETED NA

SAS-J Compared to OAGB and LSG as a Treatment for Morbid Obesity

NCT03821688

Morbid Obesity

COMPLETED NA

Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity

NCT00545805

Insulin Resistance Obesity Metabolic Syndrome X

COMPLETED PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

in this study the patients that have morbid obesity concomitant GERD will managed by sleeve gastrectomy plus cruroplasty then stripe from the momentum is fashioned and is raped around the gastroesophageal junction

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity, Morbid GERD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

sleeve gastrectomy+ cruroplasty + omental rape

Group Type EXPERIMENTAL

sleeve gastrectomy+ cruroplasty+ omental rap

Intervention Type PROCEDURE

sleeve gastrectomy+ cruroplasty+ omental rap

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sleeve gastrectomy+ cruroplasty+ omental rap

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* obese patients with BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity
* patients fit for laparoscopic surgery
* give approval to share in the study

Exclusion Criteria

* patients refused to share in the study
* patients unfit for surgery
* patients aged less than 18 and older than 60
* patient with previous upper abdominal surgery either for obesity or other diseases
* revisional bariatric procedures

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No